Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2013, Article ID 602091, 5 pages
http://dx.doi.org/10.1155/2013/602091
Research Article

Alsterpaullone, a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells through Apoptosis-Inducing Effect

1College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
2Medical Experiment and Test Center, Capital Medical University, Beijing 100069, China

Received 30 December 2012; Accepted 13 February 2013

Academic Editor: Feng Sun

Copyright © 2013 Chunying Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Zagouri, T. N. Sergentanis, D. Chrysikos, M. Filipits, and R. Bartsch, “Molecularly targeted therapies in cervical cancer. A systematic review,” Gynecologic Oncology, vol. 26, no. 2, pp. 291–303, 2012. View at Google Scholar
  2. U. Saxena, C. Sauvaget, and R. Sankaranarayanan, “Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low-resource countries: example of India,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 4, pp. 1699–1703, 2012. View at Google Scholar
  3. C. M. Martin and J. J. O'Leary, “Histology of cervical intraepithelial neoplasia and the role of biomarkers,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 25, no. 5, pp. 605–615, 2011. View at Google Scholar
  4. N. Takai, N. Kira, T. Ishii, M. Nishida, K. Nasu, and H. Narahara, “Novel chemotherapy using histone deacetylase inhibitors in cervical cancer,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 3, pp. 575–580, 2011. View at Google Scholar · View at Scopus
  5. T. Lahusen, A. de Siervi, C. Kunick, and A. M. Senderowicz, “Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential,” Molecular Carcinogenesis, vol. 36, no. 4, pp. 183–194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. V. B. Arion, A. Dobrov, S. Göschl, M. A. Jakupec, B. K. Keppler, and P. Rapta, “Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs,” Chemical Communications, vol. 48, no. 68, pp. 8559–8561, 2011. View at Google Scholar
  7. P. Rivest, M. Renaud, and J. T. Sanderson, “Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations,” Chemico-Biological Interactions, vol. 189, no. 3, pp. 177–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. V. Soni and J. W. Jacobberger, “Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase,” Cell Cycle, vol. 3, no. 3, pp. 349–357, 2004. View at Google Scholar · View at Scopus
  9. E. A. Sausville, J. Johnson, M. Alley, D. Zaharevitz, and A. M. Senderowicz, “Inhibition of CDKs as a therapeutic modality,” Annals of the New York Academy of Sciences, vol. 910, pp. 207–222, 2000. View at Google Scholar · View at Scopus
  10. M. Trevino, D. J. Stefanik, R. Rodriguez, S. Harmon, and P. M. Burton, “Induction of canonical Wnt signaling by alsterpaullone is sufficient for oral tissue fate during regeneration and embryogenesis in Nematostella vectensis,” Developmental Dynamics, vol. 240, pp. 2673–2679, 2011. View at Google Scholar
  11. A. Fabres, C. P. de Andrade, M. Guizzo et al., “Effect of GSK-3 activity, enzymatic inhibition and gene silencing by RNAi on tick oviposition and egg hatching,” Parasitology, vol. 137, no. 10, pp. 1537–1546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Soto, E. Vaz, C. Dell'Aversana, R. Álvarez, L. Altucci, and A. R. de Lera , “New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity,” Organic and Biomolecular Chemistry, vol. 14, no. 10, pp. 2101–2112, 2012. View at Google Scholar
  13. B. R. Seo, K. J. Min, S. Kim et al., “Anisomycin treatment enhances TRAIL-mediated apoptosis in renal carcinoma cells through the down-regulation of Bcl-2, c-FLIP(L) and Mcl-1,” Biochimie, vol. 12, no. 20, pp. 1–8, 2012. View at Google Scholar
  14. J. Selent, A. A. Kaczor, R. Guixà-González, P. Carrió, M. Pastor, and C. Obiol-Pardo, “Rational design of the survivin/CDK4 complex by combining protein-protein docking and molecular dynamics simulations,” Journal of Molecular Modeling. In press. View at Publisher · View at Google Scholar
  15. D. W. Zaharevitz, R. Gussio, M. Leost et al., “Discovery and initial characterization of the paullones, a novel class of smallmolecule inhibitors of cyclin-dependent kinases,” Cancer Research, vol. 59, no. 11, pp. 2566–2569, 1999. View at Google Scholar · View at Scopus